---
figid: PMC3189169__cidcir610f01_ht
figlink: /pmc/articles/PMC3189169/figure/fig1/
number: Figure 1
caption: Toll-like receptor (TLR) and type I interferon (IFN) signaling pathways.
  A, Induction of type I IFN production in cells. Viral nucleic acids are detected
  by TLRs 3, 7, 8, and 9. TLR3 activation results in signaling through the Toll–interleukin
  (IL)–1R domain–containing adapter-inducing IFN-β (TRIF)–dependent or nuclear factor
  (NF)–κβ essential modulator (NEMO)–dependent pathway. Activation of TLRs 7, 8, and
  9 results in signaling through the myeloid differentiation factor 88 (MyD88)–dependent
  pathway. Transcription factors, IFN regulatory factor (IRF) 3, IRF7, or NF-κβ, initiate
  transcription of IFN genes in the nucleus. IKK, inhibitor of NF-kB kinase subunit
  alpha or beta; IkB, inhibitor of kB; IRAK-4, IL-1R–associated kinase; RIG-1, retinoic
  acid–inducible gene 1; TRAF3, tumor necrosis factor receptor–associated factor 3.;
  TBK1, TANK-binding kinase 1. RIG 1 is a cytosolic virus sensor. B, Response of cells
  to IFN. IFNs bind to the IFN receptor and initiate signaling through the signal
  transducer and activator of transcription (STAT) pathway to induce transcription
  of IFN-stimulated genes that inhibit viral replication. Mutations in shaded genes
  have been associated with severe HSV infections, including herpes simplex encephalitis
  (HSE). Mutations in TYK-2, tyrosine kinase 2, have not been associated with HSE.
pmcid: PMC3189169
papertitle: Severe Viral Infections and Primary Immunodeficiencies.
reftext: Lesia K. Dropulic, et al. Clin Infect Dis. 2011 Nov 1;53(9):897-909.
pmc_ranked_result_index: '24771'
pathway_score: 0.915475
filename: cidcir610f01_ht.jpg
figtitle: Toll-like receptor (TLR) and type I interferon (IFN) signaling pathways
year: '2011'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3189169__cidcir610f01_ht.html
  '@type': Dataset
  description: Toll-like receptor (TLR) and type I interferon (IFN) signaling pathways.
    A, Induction of type I IFN production in cells. Viral nucleic acids are detected
    by TLRs 3, 7, 8, and 9. TLR3 activation results in signaling through the Toll–interleukin
    (IL)–1R domain–containing adapter-inducing IFN-β (TRIF)–dependent or nuclear factor
    (NF)–κβ essential modulator (NEMO)–dependent pathway. Activation of TLRs 7, 8,
    and 9 results in signaling through the myeloid differentiation factor 88 (MyD88)–dependent
    pathway. Transcription factors, IFN regulatory factor (IRF) 3, IRF7, or NF-κβ,
    initiate transcription of IFN genes in the nucleus. IKK, inhibitor of NF-kB kinase
    subunit alpha or beta; IkB, inhibitor of kB; IRAK-4, IL-1R–associated kinase;
    RIG-1, retinoic acid–inducible gene 1; TRAF3, tumor necrosis factor receptor–associated
    factor 3.; TBK1, TANK-binding kinase 1. RIG 1 is a cytosolic virus sensor. B,
    Response of cells to IFN. IFNs bind to the IFN receptor and initiate signaling
    through the signal transducer and activator of transcription (STAT) pathway to
    induce transcription of IFN-stimulated genes that inhibit viral replication. Mutations
    in shaded genes have been associated with severe HSV infections, including herpes
    simplex encephalitis (HSE). Mutations in TYK-2, tyrosine kinase 2, have not been
    associated with HSE.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA1
  - TRAF3
  - TLR9
  - IRAK1
  - TYK2
  - TLR8
  - CHUK
  - IKBKE
  - ABR
  - IRF3
  - STAT2
  - IKBKB
  - TLR7
  - TBK1
  - STAT1
  - IFNA8
  - IFNAR2
  - TLR3
  - JAK1
  - IKBKG
  - IRF9
  - MYD88
genes:
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TLR9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: IRAK-
  symbol: IRAK
  source: hgnc_alias_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: TYK-2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: TLR7,8
  symbol: TLR8
  source: hgnc_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: IKKa
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
- word: aBR
  symbol: ABR
  source: hgnc_symbol
  hgnc_symbol: ABR
  entrez: '29'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: STAT-2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: TLR7,8
  symbol: TLR7
  source: hgnc_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TBK1
  symbol: TBK1
  source: hgnc_symbol
  hgnc_symbol: TBK1
  entrez: '29110'
- word: STAT-1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IFN-a.B
  symbol: IFN-alphaB
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IFNaBR
  symbol: IFNABR
  source: hgnc_prev_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: IFN-a8
  symbol: IFNA8
  source: hgnc_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: JAK-1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
chemicals: []
diseases: []
---
